Teladoc Health Price to Book Ratio 2014-2024 | TDOC
Historical price to book ratio values for Teladoc Health (TDOC) over the last 10 years. The current price to book ratio for Teladoc Health as of September 27, 2024 is 0.96.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Teladoc Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-09-26 | 8.41 | 0.96 | |
| 2024-06-30 | 9.78 | $8.78 | 1.11 |
| 2024-03-31 | 15.10 | $13.52 | 1.12 |
| 2023-12-31 | 21.55 | $13.96 | 1.54 |
| 2023-09-30 | 18.59 | $13.86 | 1.34 |
| 2023-06-30 | 25.32 | $13.92 | 1.82 |
| 2023-03-31 | 25.90 | $13.98 | 1.85 |
| 2022-12-31 | 23.65 | $14.17 | 1.67 |
| 2022-09-30 | 25.35 | $37.32 | 0.68 |
| 2022-06-30 | 33.21 | $37.58 | 0.88 |
| 2022-03-31 | 72.13 | $56.63 | 1.27 |
| 2021-12-31 | 91.82 | $99.99 | 0.92 |
| 2021-09-30 | 126.81 | $99.91 | 1.27 |
| 2021-06-30 | 166.29 | $100.34 | 1.66 |
| 2021-03-31 | 181.75 | $102.52 | 1.77 |
| 2020-12-31 | 199.96 | $105.69 | 1.89 |
| 2020-09-30 | 219.24 | $26.45 | 8.29 |
| 2020-06-30 | 190.84 | $16.37 | 11.66 |
| 2020-03-31 | 155.01 | $13.50 | 11.48 |
| 2019-12-31 | 83.72 | $13.94 | 6.01 |
| 2019-09-30 | 67.72 | $13.73 | 4.93 |
| 2019-06-30 | 66.41 | $13.94 | 4.76 |
| 2019-03-31 | 55.60 | $14.02 | 3.97 |
| 2018-12-31 | 49.57 | $14.37 | 3.45 |
| 2018-09-30 | 86.35 | $14.68 | 5.88 |
| 2018-06-30 | 58.05 | $10.88 | 5.34 |
| 2018-03-31 | 40.30 | $8.85 | 4.56 |
| 2017-12-31 | 34.85 | $9.08 | 3.84 |
| 2017-09-30 | 33.15 | $7.85 | 4.22 |
| 2017-06-30 | 34.70 | $7.29 | 4.76 |
| 2017-03-31 | 25.00 | $6.32 | 3.96 |
| 2016-12-31 | 16.50 | $5.00 | 3.30 |
| 2016-09-30 | 18.31 | $5.26 | 3.48 |
| 2016-06-30 | 16.02 | $3.92 | 4.08 |
| 2016-03-31 | 9.60 | $4.27 | 2.25 |
| 2015-12-31 | 17.96 | $4.64 | 3.87 |
| 2015-09-30 | 22.29 | $5.01 | 4.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.449B | $2.602B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.497B | 14.81 |
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $17.560B | 26.63 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Revvity (RVTY) | United States | $15.548B | 27.23 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| HealthEquity (HQY) | United States | $6.980B | 37.88 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Pediatrix Medical (MD) | United States | $0.967B | 10.52 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |